Group psilocybin retreat for healthcare workers with depression
Treatments studied
Part of Mental health clinical trials.
This trial tests whether group psilocybin retreats can help healthcare workers who have lost meaning in their work and feel depressed. You would take psilocybin in a supportive retreat setting to see if it restores your sense of purpose and improves your mood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a doctor, nurse, nurse practitioner, or physician assistant currently seeing patients.
- You are between 25 and 70 years old.
- You feel that the deep meaning in your work has faded over the past 5 years.
- You have at least moderate symptoms of depression (scoring 10 or higher on a standard depression questionnaire).
- You can attend all preparation sessions and the group retreat.
- You can speak English well enough to take part in group discussions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This trial tests whether a medicine called psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help treat depression. You would have a few sessions with a therapist and receive the medicine in a safe setting, which might improve your mood.
This trial tests whether psilocybin can help people with major depression who are currently having a depressive episode. It aims to understand how the treatment works and if it is safe and effective.
This trial tests if psilocybin, a psychedelic drug, can help people with long-term low back pain who also have depression. If you qualify, you'll receive psilocybin in a controlled setting, and researchers will see how it affects your pain and mood.
This trial tests whether a treatment called psilocybin (a hallucinogen that can help with depression) combined with group therapy can improve symptoms of depression. It requires participants to have significant depression symptoms and a support person to drive them home after each session.
This trial tests whether a single dose of psilocybin can help hospitalized patients with tough-to-treat depression. It focuses on people who haven't improved with standard antidepressants and need a new option.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.